NCT02444572View on ClinicalTrials.gov

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®

PHASE4CompletedINTERVENTIONAL

Enrollment

168

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2020

Study Completion Date

July 10, 2020

Conditions

Gastrointestinal NeoplasmsThromboembolic Event

Interventions

DRUG

Enoxaparin 4000 IU

Trial Locations (1)

1006

Charles Nicolle Hospital, Tunis

All Listed Sponsors

lead

Les Laboratoires des Médicaments Stériles

INDUSTRY

NCT02444572 - Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® | Biotech Hunter | Biotech Hunter